Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01725048 · ClinicalTrials.gov registry record · Early Phase 1
Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer
A Early Phase 1 study, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 21
- Enrollment target
NCT01725048 is a Early Phase 1 study that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 21 participants.
The verdict
NCT01725048, a Early Phase 1 study, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
This is a pilot study to test the hypothesis that the antidepressants mirtazapine and citalopram are effective treatment for major depressive disorder (MDD) in cancer patients.
Interventions
- DRUG Mirtazapine
- DRUG Citalopram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01725048
The ClinicalTrials.gov registry entry for NCT01725048 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mirtazapine is the first listed.
NCT01725048 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01725048 about?
NCT01725048 is a clinical study titled "Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer". This is a pilot study to test the hypothesis that the antidepressants mirtazapine and citalopram are effective treatment for major depressive disorder (MDD) in cancer patients.
What is the current status of trial NCT01725048?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 21 participants. The study started on 2011-01. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01725048?
The interventions under investigation include: Mirtazapine (DRUG), Citalopram (DRUG).
Who is sponsoring clinical trial NCT01725048?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.